HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy
Vincenzo Pitini, Giuseppe Sturniolo, Carmela Arrigo, Silvana Leonardi, Salvatrice Pino, Giuseppe AltavillaVolume:
150
Year:
2010
Language:
english
Pages:
1
DOI:
10.1111/j.1365-2141.2010.08154.x
File:
PDF, 366 KB
english, 2010